• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A smart tool for non expert clinicians for the dissemination of the MDS criteria for progressive supranuclear palsy.一种供非专家临床医生使用的智能工具,用于传播进行性核上性麻痹的MDS标准。
Neurol Sci. 2025 May;46(5):1959-1964. doi: 10.1007/s10072-025-07996-0. Epub 2025 Jan 11.
2
Clinical prognostic factors in progressive supranuclear palsy: Implications for clinical trials.进行性核上性麻痹的临床预后因素:对临床试验的启示。
J Parkinsons Dis. 2024 Nov;14(8):1652-1658. doi: 10.1177/1877718X241291996. Epub 2024 Dec 8.
3
Associations between neuropsychological profile and regional brain FDG uptake in progressive supranuclear palsy.进行性核上性麻痹患者神经心理学特征与脑区氟代脱氧葡萄糖摄取之间的关联
J Parkinsons Dis. 2025 Jun;15(4):904-912. doi: 10.1177/1877718X251343080. Epub 2025 May 25.
4
Effectiveness of allied health therapy in the symptomatic management of progressive supranuclear palsy: a systematic review.联合健康疗法对进行性核上性麻痹症状管理的有效性:一项系统评价
JBI Database System Rev Implement Rep. 2016 Jun;14(6):148-95. doi: 10.11124/JBISRIR-2016-2002352.
5
Patterns of brain volume and metabolism predict clinical features in the progressive supranuclear palsy spectrum.脑容量和代谢模式可预测进行性核上性麻痹谱系障碍的临床特征。
Brain Commun. 2024 Jul 16;6(4):fcae233. doi: 10.1093/braincomms/fcae233. eCollection 2024.
6
Noradrenaline for progressive supranuclear palsy syndromes (NORAPS): a randomised, double-blind, placebo-controlled, crossover Phase IIb clinical trial evaluating the efficacy and safety of oral atomoxetine for treating cognitive and behavioural changes in people with progressive supranuclear palsy syndromes in the UK.去甲肾上腺素用于进行性核上性麻痹综合征(NORAPS):一项随机、双盲、安慰剂对照、交叉的IIb期临床试验,在英国评估口服托莫西汀治疗进行性核上性麻痹综合征患者认知和行为改变的疗效和安全性。
BMJ Open. 2025 Jul 28;15(7):e099577. doi: 10.1136/bmjopen-2025-099577.
7
The Role of MicroRNAs in Progressive Supranuclear Palsy-A Systematic Review.微小 RNA 在进行性核上性麻痹中的作用-系统评价。
Int J Mol Sci. 2024 Jul 28;25(15):8243. doi: 10.3390/ijms25158243.
8
Which ante mortem clinical features predict progressive supranuclear palsy pathology?哪些生前临床特征可预测进行性核上性麻痹病理?
Mov Disord. 2017 Jul;32(7):995-1005. doi: 10.1002/mds.27034. Epub 2017 May 13.
9
Predictors of survival in progressive supranuclear palsy and multiple system atrophy: a systematic review and meta-analysis.进行性核上性麻痹和多系统萎缩生存预测因素的系统评价和荟萃分析。
J Neurol Neurosurg Psychiatry. 2017 May;88(5):402-411. doi: 10.1136/jnnp-2016-314956. Epub 2017 Mar 1.
10
Progressive supranuclear palsy: current approach and challenges to diagnosis and treatment.进行性核上性麻痹:当前的诊断和治疗方法及挑战。
Curr Opin Neurol. 2023 Aug 1;36(4):309-316. doi: 10.1097/WCO.0000000000001163. Epub 2023 May 31.

本文引用的文献

1
Prediagnostic Progressive Supranuclear Palsy - Insights from the UK Biobank.诊断前进行性核上性麻痹——来自英国生物银行的见解
Parkinsonism Relat Disord. 2022 Feb;95:59-64. doi: 10.1016/j.parkreldis.2022.01.004. Epub 2022 Jan 11.
2
Clinical Features Observed in General Practice Associated With the Subsequent Diagnosis of Progressive Supranuclear Palsy.全科医疗中观察到的与进行性核上性麻痹后续诊断相关的临床特征。
Front Neurol. 2021 Apr 22;12:637176. doi: 10.3389/fneur.2021.637176. eCollection 2021.
3
The "round the houses" sign and "zig-zag" sign in progressive supranuclear palsy and other conditions.进行性核上性麻痹及其他病症中的“绕屋”征和“锯齿状”征
Parkinsonism Relat Disord. 2020 Dec;81:94-95. doi: 10.1016/j.parkreldis.2020.10.030. Epub 2020 Oct 19.
4
Video-tutorial for the Movement Disorder Society criteria for progressive supranuclear palsy.进行性核上性麻痹运动障碍学会标准的视频教程。
Parkinsonism Relat Disord. 2020 Sep;78:200-203. doi: 10.1016/j.parkreldis.2020.06.030. Epub 2020 Sep 22.
5
Clinical Conditions "Suggestive of Progressive Supranuclear Palsy"-Diagnostic Performance.提示进行性核上性麻痹的临床情况-诊断性能。
Mov Disord. 2020 Dec;35(12):2301-2313. doi: 10.1002/mds.28263. Epub 2020 Sep 11.
6
The "zig-zag" sign in Progressive Supranuclear Palsy.进行性核上性麻痹中的“锯齿状”征。
Parkinsonism Relat Disord. 2020 Oct;79:86-87. doi: 10.1016/j.parkreldis.2020.08.014. Epub 2020 Aug 23.
7
The "gunslinger" sign in progressive supranuclear palsy - Richardson variant.进行性核上性麻痹-理查森变异型中的“神枪手”征。
J Neurol Sci. 2020 Nov 15;418:117108. doi: 10.1016/j.jns.2020.117108. Epub 2020 Aug 31.
8
Prediagnostic motor and non-motor symptoms in progressive supranuclear palsy: The step-back PSP study.进行性核上性麻痹的预诊断运动和非运动症状:后退 PSP 研究。
Parkinsonism Relat Disord. 2020 May;74:67-73. doi: 10.1016/j.parkreldis.2020.03.003. Epub 2020 Mar 13.
9
Reactions to Multiple Ascending Doses of the Microtubule Stabilizer TPI-287 in Patients With Alzheimer Disease, Progressive Supranuclear Palsy, and Corticobasal Syndrome: A Randomized Clinical Trial.在阿尔茨海默病、进行性核上性麻痹和皮质基底节综合征患者中,对微管稳定剂 TPI-287 的多次递增剂量的反应:一项随机临床试验。
JAMA Neurol. 2020 Feb 1;77(2):215-224. doi: 10.1001/jamaneurol.2019.3812.
10
Validation of the movement disorder society criteria for the diagnosis of 4-repeat tauopathies.验证运动障碍学会标准对 4 重复型 tau 病的诊断。
Mov Disord. 2020 Jan;35(1):171-176. doi: 10.1002/mds.27872. Epub 2019 Sep 30.

一种供非专家临床医生使用的智能工具,用于传播进行性核上性麻痹的MDS标准。

A smart tool for non expert clinicians for the dissemination of the MDS criteria for progressive supranuclear palsy.

作者信息

Picillo Marina, Abate Filomena, Canoro Vincenzo, Tepedino Maria Francesca, Barone Paolo, Erro Roberto

机构信息

Center for Neurodegenerative Diseases (CEMAND), Department of Medicine, Surgery and Dentistry, "Scuola Medica Salernitana", University of Salerno, Salerno, Italy.

Department of Neurology, "Umberto I" Hospital, Nocera Inferiore, Salerno, Italy.

出版信息

Neurol Sci. 2025 May;46(5):1959-1964. doi: 10.1007/s10072-025-07996-0. Epub 2025 Jan 11.

DOI:10.1007/s10072-025-07996-0
PMID:39794607
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12003616/
Abstract

Due to the variety of clinical phenotypes and the massive clinical overlap with other neurodegenerative diseases, the diagnosis of Progressive Supranuclear Palsy (PSP) remains a major challenge. Notwithstanding, early and reliable clinical diagnosis of PSP is highly warranted for estimation of prognosis, appropriate allocation to therapeutic trials and development of new diagnostic tools. As reliable biomarkers are lacking, PSP diagnosis relies on the application of the clinical criteria promoted by the International Parkinson and Movement Disorder Society (MDS). Despite providing a framework including all the main PSP cornerstones (ocular dysfunction and postural instability, akinesia and cognitive dysfunction), the application of the MDS PSP criteria is complex and not straightforward to apply in a clinical setting. Herein we propose a practical tool, including a video-guided slide-set and a smartsheet, to disseminate the MDS PSP clinical criteria among healthy practitioners and increase confidence in non expert clinicians towards suspicion and diagnosis of PSP. The video-guided slide set may serve as a teaching resource for both general neurologists and practitioners, while the smartsheet may represent a valid support in attributing the degree of diagnostic certainty and phenotype based on the identified clinical features. Application of our tool may improve early recognition of patients in primary and secondary care and determine a prompt referral to third level movement disorder centers for consideration in clinical trials testing disease-modifying treatments.

摘要

由于临床表型的多样性以及与其他神经退行性疾病存在大量临床重叠,进行性核上性麻痹(PSP)的诊断仍然是一项重大挑战。尽管如此,为了评估预后、合理分配到治疗试验以及开发新的诊断工具,PSP的早期可靠临床诊断非常必要。由于缺乏可靠的生物标志物,PSP的诊断依赖于国际帕金森和运动障碍协会(MDS)推广的临床标准的应用。尽管MDS PSP标准提供了一个包含所有主要PSP基石(眼功能障碍和姿势不稳、运动不能和认知功能障碍)的框架,但其应用复杂,在临床环境中不易应用。在此,我们提出一种实用工具,包括视频引导幻灯片集和智能工作表,以在临床医生中传播MDS PSP临床标准,并增强非专家临床医生对PSP怀疑和诊断的信心。视频引导幻灯片集可作为普通神经科医生和临床医生的教学资源,而智能工作表可在根据已确定的临床特征确定诊断确定性程度和表型方面提供有效支持。应用我们的工具可能会改善初级和二级护理中患者的早期识别,并确定迅速转诊至三级运动障碍中心,以便在测试疾病修饰治疗的临床试验中进行考虑。